Correction: Belimumab for Treating Active AutoantibodyPositive Systemic Lupus Erythematosus: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Pharmacoeconomics
; 41(11): 1551, 2023 Nov.
Article
in En
| MEDLINE
| ID: mdl-37665503
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Pharmacoeconomics
Journal subject:
FARMACOLOGIA
/
TERAPIA POR MEDICAMENTOS
Year:
2023
Document type:
Article
Affiliation country:
Netherlands